Q3 2024 13F Holders as of 9/30/2024
-
Type / Class
-
Equity / Common Stock, par value $0.0001 per share
-
Shares outstanding
-
56.3M
-
Number of holders
-
47
-
Total 13F shares, excl. options
-
19M
-
Shares change
-
+4.73M
-
Total reported value, excl. options
-
$97.8M
-
Value change
-
+$23.8M
-
Number of buys
-
25
-
Number of sells
-
-14
-
Price
-
$5.14
Significant Holders of Orchestra BioMed Holdings, Inc. - Common Stock, par value $0.0001 per share (OBIO) as of Q3 2024
52 filings reported holding OBIO - Orchestra BioMed Holdings, Inc. - Common Stock, par value $0.0001 per share as of Q3 2024.
Orchestra BioMed Holdings, Inc. - Common Stock, par value $0.0001 per share (OBIO) has 47 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 19M shares
of 56.3M outstanding shares and own 33.77% of the company stock.
Largest 10 shareholders include RTW INVESTMENTS, LP (8.21M shares), PERCEPTIVE ADVISORS LLC (4.59M shares), BlackRock, Inc. (1.94M shares), VANGUARD GROUP INC (1.31M shares), GEODE CAPITAL MANAGEMENT, LLC (567K shares), PRICE T ROWE ASSOCIATES INC /MD/ (513K shares), STATE STREET CORP (430K shares), Boxer Capital, LLC (238K shares), NORTHERN TRUST CORP (231K shares), and CHARLES SCHWAB INVESTMENT MANAGEMENT INC (217K shares).
This table shows the top 47 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.